Female mice exposed to soy isoflavones (ISO) during early postnatal life have improved bone outcomes at adulthood. Since long-lasting effects may be mediated by DNA methylation, we hypothesized that providing supplemental folic acid (FA), a methyl donor, during early life, would enhance the positive effect of ISO to bone health. Bone-specific gene expression patterns were studied to understand potential mechanisms. CD-1 dams (n=36) were randomized to adequate or supplemental levels of FA (2 or 8 mg/kg diet) during pregnancy and lactation, and offspring received corn oil or ISO (7 mg/kg body weight/d) from postnatal day 1 to 10. From weaning, pups were fed an adequate FA diet and were studied to 4 months of age. Female offspring exposed to supplemental FA+ISO had higher bone mineral density (BMD), trabecular connectivity and peak load at the lumbar spine compared to females exposed to adequate FA. Female offspring exposed to adequate FA+ISO or supplemental FA had higher (Pb.05) BMD and greater resistance to fracture at the lumbar spine and the femur; higher trabecular connectivity at the lumbar spine; and lower expression of DNA methyltransferase 3a (Dnmt3a) and neuropeptide Y (NPY) in the femur compared to mice exposed to adequate FA. In addition, only mice exposed to adequate FA+ISO had microstructural improvements at the femur neck and higher serum osteoprotegrin (OPG) and insulin growth factor-I (IGF-I). In summary, exposure to supplemental FA did not enhance the positive effect of ISO in bone. However, exposure to adequate FA+ISO or supplemental FA improved bone at least in part by suppressing Dnmt3a and NPY.
Introduction
Diet during early life can influence the development of physiological and endocrine systems in ways that affect the prevalence of noncommunicable diseases [1] [2] [3] . We have previously shown that female mice exposed to adequate folic acid+soy isoflavones (adequate FA+ISO) during early postnatal life, at levels similar to that of infants consuming soy protein formula [4] , have higher bone mineral density (BMD), improved trabecular connectivity and greater resistance to fracture at adulthood [5] [6] [7] [8] [9] , as well as attenuated deterioration of bone tissue after ovariectomy compared to females exposed to adequate FA alone [7] . However, the mechanism has not been elucidated.
Soy isoflavones are bioactives that can program epigenetic patterns [10] . Studies using agouti mice have shown that dams fed a diet rich in genistein, the most abundant ISO in soy protein, during pregnancy and lactation give birth to offspring that have hypermethylated CpG islands in the promoter of the agouti gene, higher prevalence of pseudo-agouti phenotype and a lower incidence of obesity at 15 months of age compared to control animals [10] . Postnatal exposure to ISO also stimulates hypermethylation of specific repetitive elements that coincide with significant down-regulation of estrogen-responsive genes involved in hematopoiesis and bone marrow cell development [11] . Thus, it is possible that skeletal improvements at adulthood, induced by early life exposure to ISO, are in part mediated by reprogramming of DNA methylation patterns in the epigenome.
DNA methylation is driven by a group of enzymes called DNA methyltransferases that recognize CpG dinucleotides of palindromic sequences and catalyze the transfer of one-carbon group from a methyl donor to the cytosine residue. As such, changes in the expression of DNA methyltransferase or the availability of methyl donors/acceptors can alter DNA methylation patterns. To date, three DNA methyltransferases have been identified [12] . DNA methyltransferase-1 (Dnmt-1) is responsible for maintaining patterns of CpG dinuleotides throughout replication cycles, while Dnmt-3a and -3b are de novo methyltransferases that set up DNA methylation patterns early in development. In 4-week-old rats injected with human neuroblastoma SK-N-SH cells that had been isolated from toddlers, treatment with genistein enhanced the expression of tumor suppressor CD5 and p53 by down-regulating the expression of Dnmt-3b [13] . Suppression of Dnmt-3a has also been observed in uterine tissue of mice exposed to diethylstilbestrol (an environmental estrogen) during early life [14] . DNA methyltransferases use S-adenosyl methionine (SAM) as the methyl donor for DNA. In the rate-limiting step of the SAM cycle, methylenetetrahydrofolate reductase (MTHFR) irreversibly reduces a derivative of FA 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate. As such, the availability of FA has an important role in how DNA methyltransferases modulate methylation patterns. The combined effect of administering FA with ISO has been demonstrated in a study of pregnant rats [15] . In utero exposure to FA (0.7 mg/kg, a level lower than in the control AIN93G diet) and ISO (160 mg/kg) supported post-neural tube closure to a greater extent than either treatment alone [15] . In line with these findings, we reported that early-life exposure to adequate FA (2 mg/kg)+ISO [7 mg/kg of body weight (bw)] but not supplemental FA (8 mg/kg)+ISO (7 mg/kg of bw) results in higher BMD and greater resistance to fracture at the femur and lumbar spine in male CD-1 mice [16] . Based on our published studies, female mice have a more pronounced response to environmental estrogens (i.e. diethylstilbestrol and ISO) than males [6, 7, 17] so female mice were studied to elucidate the mechanism by which FA and ISO modulate bone development.
To prevent pregnancy-induced anemia and to correct abnormal folate metabolism or subtle folate inadequacy that may result in abnormal fetal development, women of child-bearing age are encouraged to eat folate-rich foods and take a supplement containing 400 μg of FA [18] . In addition, many countries, including the United States and Canada, have introduced mandatory folate fortification of grain products to ensure that all women of child-bearing age have adequate levels of folate before getting pregnant. Due to these initiatives, many women of childbearing age have higher (N906 nmol/L) than recommended folate concentrations [19] . If some of these women feed their neonates with soy protein formula that are fortified with FA (2-4 mg/L) and naturally contain high amounts of ISO (32-47 mg/L) [20, 21] their infants may have markedly higher concentration of circulating FA (2.3 fold higher) and ISO (10 fold higher) than infants fed breast milk or cow's milk formula [20] [21] [22] . Therefore, there is an ongoing need to characterize how early life exposure to FA and ISO affects growth and development. The purpose of this study was to determine if providing supplemental FA, a methyl donor, during early life, can enhance the ISOinduced benefits to bone health. This study also determined bonespecific gene expression patterns to elucidate potential mechanisms.
Methods

Animals and treatment
Seven-week-old male and female CD-1 mice (Charles River Canada) housed in the Department of Comparative Medicine at the University of Toronto under standard environmental conditions (23°C, 50% humidity, 12 h:12 h light-dark cycle) were randomized to an amino acid based diet (Dyets, Bethlehem, PA, USA) fortified with 2 or 8 mg of FA/kg and devoid of ISO. The amino acid diet was used because it is the only rodent diet that does not contain any natural folate, allowing investigators to more tightly control the level of FA within a diet. The diet containing 2 mg of FA was used to represent the basal dietary requirement for rodents while [23] , the 8 mg of FA diet was used to mimic the amount of FA that pregnant women may obtain by consuming FA supplements and FA-fortified foods; this supplemental level of FA has been shown to provide a degree of chemoprevention against colorectal cancer in rodent models [24] [25] [26] [27] .
After one week of adaptation to the environment and diet, mice were mated harem style. Once females were identified as being pregnant they were housed in individual cages under standard environmental conditions (23°C, 50% humidity, 12:12h light-dark cycle), and remained on their respective diets. Water was provided ad libitum. Offspring of dams that delivered 8-12 pups on the same day were fed the same FA diet and were cross-fostered by assigning a maximum of one male and one female pup from each dam to a litter. Cross-fostered litters on supplemental or adequate FA diet were then randomized to ISO or corn oil treatment. Control pups received corn oil as it is used as the vehicle for ISO [6] [7] [8] . The ISO groups received a daily dose containing 0.010 mg of daidzein and 0.025 mg of genistein per pup (7 mg/kg bw/day). This dose resembles the concentration of daidzein and genistein in infants fed soy protein formula [4, 6] . All ISO mixtures were prepared fresh prior to treatment by being solubilized in 1 ml of dimethyl sulfoxide (DMSO) and suspended in corn oil. Treatments were administered in the morning from postnatal day (PND) 1 to 10 via daily subcutaneous injections using a 3/10 cc insulin syringe with a 30 gauge needle and a 12.7 mm needle length. The 10-day duration of exposure was selected to target the stage of development when CD-1 mice have low concentrations of endogenous sex steroids and there is a probability of inducing programming effects at both the femur and lumbar spine [28] . The total volume of treatment was 20 μl. At weaning (PND 21), all female offspring were housed 3-4 per cage and fed an amino acid diet containing 2 mg of FA/ kg. Body weight of offspring was measured at birth, 7 and 21 days of age, and subsequently every week until 16 weeks of age using an electronic scale (Denver Instrument XP-1500). For time points where there was a statistically significant change in body weight between groups the percent difference was calculated. The mean body weight gain of each experimental group was calculated by subtracting the 4 week body weight measures from the 16 week body weight measures. At 6 weeks of age, a subset of mice (n=6/group) was euthanized by carbon dioxide and cervical dislocation, to extract RNA from femurs and perform microarray analyses. All remaining females were euthanized at age 16 weeks. The offspring groups were supplemental folic acid+isoflavones (supplemental FA+ISO); adequate folic acid+ isoflavones (adequate FA+ISO); supplemental folic acid (supplemental FA) and adequate folic acid (adequate FA).
All protocols for animal use and treatment were approved by the University of Toronto Animal Care Committee and were in compliance with the guidelines of the Canadian Council on Animal Care [29] .
BMD of femurs and LV1-LV3
To measure bone mineral density (BMD), femurs and intact lumbar vertebrae (LV1-LV3) stored at −80°C were analyzed using dual energy x-ray absorptiometry (DEXA) (pSabre, Orthometrix, White Plains, NY, USA) and a specialized software program (Host Software Version: 3.9.4; Scanner Software Version: 1.2.0) as previously described [6, 7, 9] . Scans were conducted in air at room temperature using a speed of 2 mm/min and a resolution of 0.01 × 0.01 mm.
Peak load of femurs and LV2
Femurs and LV2 were hydrated in 0.9% saline solution for 3 hrs at room temperature. Using an electronic balance (Sartorius AG, Goettingen, Germany) the weight of the femur and LV2 was determined. Femur length was measured, from the proximal tip of the femoral head to the distal tip of the medial condyle, using electronic precision calipers (Cedarlane Laboratories, Hornby, ON, Canada). At the femur midpoint, anterior-posterior and mediolateral width was measured. To determine peak load, the maximal force a bone can withstand before fracture occurs, of the lumbar spine and femur midpoint, a materials testing system (Model 4442, Intron, Canton, MA, USA) and specialized software (Series IX Automated Materials Tester, Version 8.15.00) were used as previously described [6, 7, 9, 30] . Peak load was identified as the first peak of the loaddisplacement curve.
Microarchitecture of femur and LV4
The 3D microarchitecture of femur neck and lumbar spine were evaluated using a high resolution (8 μm) μCT imaging system (GE Healthcare System, Model # MS0900325-0010). Scans were conducted in water and used an x-ray tube source of 80kV and an x-ray intensity of 80 μA. During scanning, a 1 mm thick aluminum filter was employed to minimize beam hardening effects, and a bath was placed over top of the specimen holder to improve image quality and increase overall accuracy by preventing interference of the refracted wavelength of x-rays with unrefracted x-rays. For each scan, 500 radiographic projections were acquired over an angular range of 180°(angular step of 45°) with a fixed exposure time of 3 sec per frame. From 2D radiographic projections, a 3D structural image was reconstructed (voxel size of 0.014 mm 3 ) using a 3D Gaussian filter that partly suppresses the volume noise. Femur neck was analyzed from the bottom edge of the femur head to the narrowest part of the femur shaft by selecting a fixed region of 1.5 mm. Similarly, LV4 was analyzed by selecting a fixed region of 1 mm at LV4 midpoint. Unbiased 3D microstructural properties of trabecular bone (i.e. trabecular bone volume, BV/TV; trabecular surface area, BS/BV; trabecular thickness, Tb.Th; trabecular number, Tb.N; trabecular separation, Tb.Sp) were calculated using methods based on distance transformation of the binarized images.
Biochemical analyses
Serum adrenocorticotropic hormone (ACTH), osteoprotegrin (OPG), receptor activator for nuclear factor kB ligand (RANKL), osteocalcin, insulin-like growth factor (IGF-I) and IGF binding proteins (IGFBP-1,2,3,5,6,7) were measured using commercially available kits (Milliplex MAP, based on the Luminex xMAP technology by Millipore, Billerica, MA, USA).
Bone microarray and real-time reverse transcription polymerase chain reaction
After aspiration of bone marrow, total RNA was isolated from fresh femurs using Trizol reagent (Invitrogen, San Diego, CA, USA) according to the manufacturer's protocol. RNA integrity of isolated RNA was assessed by Agilent 2100 Bioanalyzer on the RNA 600 Nano kit (Agilent Technologies, Santa Clara, CA, USA), and only samples with an RNA Integrity Number (RIN) of 8 or higher were used for analyses. In total, the RNA of 24 samples, 6 from each group were analyzed. The Illumina TotalPrep-96 RNA Amplification kit (Ambion, Wilmington, DE, USA) was used for RNA amplification of each sample according to manufacturer's instructions. In short, 200 ng of RNA sample was reversed transcribed with an oligo(dT) primer with a T7 promoter using ArrayScript reverse transcriptase. cDNA generated from this reaction then underwent a second synthesis and cleanup to generate a template for in vitro transcription with T7 RNA Polymerase. In vitro transcription amplification generates biotinylated, amtisense RNA copies of each mRNA in the sample (cRNA) that was then used for hybridization with Illumina beadchips. For each sample, 1.5 ug of the generated cRNA was hybridized onto the Mouse WG-6 V2 Beadchips (Illumina, San Diego, USA) according to manufacturer's protocol. All samples passed Illumina's sample dependent and independent quality control metrics. Microarray data was processed using the Bioconductor R (v2.14.1) framework and Lumi package (www.bioconductor.org) and was imported into GeneSpring v11.5.1 for analysis. During import, data was normalized using a standard quantile-based (for Illumina arrays) normalization followed by a "per probe" median-centered normalization. All data analysis and visualization were performed on log2 transformed data. A total of 45281 probes are represented on the Mouse WG-6v2r3 array. For statistical tests, data was first filtered to remove the confounding effect probes that showed no signal. Only probes that were in the upper 80th percentile of the distribution of intensities in 100% of any of the four groups were allowed to pass through this filtering. The filtered set contained 30269 probes. A threshold of 1.5 fold change was used to find a list of differentially expressed genes among different FA treatments with and without ISO. Microarray experiments were performed at the University Health Network (UHN) Microarray Centre, Toronto, Canada.
To validate the results obtained by the Mouse WG-6 V2 Beadchip and quantify expression of DNA methyltransferases (Dnmt1, Dnmt3a and Dnmt3b), we performed TaqMan verification using One-Step Plus sequence detection system (Applied Biosystems, Foster City, CA, USA). The TaqMan probe assays (Applied Biosystems, Foster City, CA) were carried out in a final 20 μl reaction volume using 1 μl of commercially available primer mix, 10 ul of TaqMan Universal Master Mix and 2 μl of sample extracted DNA. Thermal cycling proceeded with 40 cycles of 95°C for 15 s and 60°C for 1 min. Input RNA amounts were calculated with relative standard curves for both the mRNAs of interest and β-actin (Actb). In all cases reactions were performed in triplicates using the same six independent samples of bone RNA.
Statistical analyses
Statistical analyses were performed using SigmaStat (Version 3.5, Jandel Scientific). Data are expressed as mean±S.E.M. One-way ANOVA followed by a Student Newman-Keul's post hoc test was used to analyze differences in body weight at birth. Repeated measures two-way ANOVA followed by a Student-Newman-Keul's post hoc test were used to analyze difference in body weight at one week intervals from 3 to 16 weeks of age. For microarray analyses, an ANOVA using an FDR Benjamini and Hochberg multiple testing correction threshold of qb.05 was performed. For all other measures, two-way ANOVA was used with FA and ISO as the main effects. For data that did not follow a normal distribution, a Kruskal-Wallis twoway ANOVA on ranks followed by Student Newman-Keul's post hoc test was used to determine differences among groups. Statistical significance was determined as P≤.05. For microarray analyses, an ANOVA using an FDR Benjamini and Hochberg multiple testing correction threshold of qb.05 was performed.
Results
3.1.
Early life exposure to ISO promotes weight gain in female mice when given in combination with an adequate but not supplemental level of FA From birth through weaning there were no significant differences in body weight among groups (Fig. 1 ). There were also no significant differences in body weight between female mice exposed to supplemental FA+ISO, supplemental FA alone or adequate FA from weaning through 16 weeks of age (Fig. 1B) . In contrast, female mice exposed to adequate FA+ISO had 10-20% higher (Pb.05) body weight from 4 through 16 weeks of age than female mice exposed to adequate FA alone (Fig. 1A) . The mean weight gain from weaning to 16 weeks of age was not significantly different between female mice exposed to supplemental FA+ISO (25.6±1.60 g), supplemental FA alone (25.0± 1.48 g) or adequate FA (24.8±0.94 g) but, females exposed to adequate FA+ISO (28.2±1.31 g) had a slightly higher gain in body weight (P=.055) than females exposed to adequate FA. For all groups, body weight of mice was within the normal growth range (depicted by the shaded area) [31] .
3.2. Early life exposure to supplemental FA+ISO, adequate FA+ISO or supplemental FA alone has a positive effect on BMD and bone strength of femurs and lumbar spine in female mice at adulthood There was an overall interaction effect (FA × ISO) on femur and lumbar spine BMD and peak load. Female offspring exposed to supplemental FA+ISO had higher (Pb.05) LV1-3 BMD and peak load of femur midpoint and LV2 than those exposed to adequate FA (Fig. 2) . However, exposure to supplemental FA+ISO did not result in higher BMD or greater bone strength at the femur or lumbar spine compared with exposure to adequate FA+ISO or supplemental FA. Female offspring exposed to adequate FA+ISO or supplemental FA had higher (Pb.05) BMD of whole femur and LV1-3, and higher (Pb.05) peak load at the femur midpoint when compared to mice exposed to adequate FA (Fig. 2). 3.3. Early life exposure to adequate FA+ISO or supplemental FA alone results in higher BV/TV and trabecular number, and lower trabecular separation in female mice at adulthood Exposure to FA and ISO both had an independent effect on BV/TV of LV4. Female offspring exposed to supplemental FA (P=.001) had higher BV/TV of LV4 than females exposed to adequate FA (Table 1) . Fig. 1 . Body weight from birth through 16 weeks of age of female mice whose mothers' were fed adequate (A) or supplemental (B) FA during pregnancy and lactation, and who from PND 1-10 were treated with subcutaneous injections of corn oil or ISO. The shaded area represents the normal growth range of CD-1 mice [31] . Values are expressed as means±S.E.M., n=12-18 *Different from corresponding corn oil treated females, Pb.05. The percentages represent the percent difference in body weight between groups at the specific age. Abbreviations: FAfolic acid; ISO -soy isoflavones. Exposure to ISO resulted in higher (Pb.001) BV/TV than corn oil. There were no differences in BS/BV or Th.Th. at the lumbar spine between groups (Table 1) . Female offspring exposed to supplemental FA had higher (P=.05) Tb.N. and lower (P=.009) Tb.Sp. of LV4 than females exposed to adequate FA. Females exposed to ISO had higher (P=.02) Tb.N. and lower (Pb.001) Tb.Sp. of LV4 than females exposed to corn oil. There were no differences in BV/TV or Tb.Sp. at the femur neck between groups. There was an overall interaction effect (FA × ISO) (Pb.05) on femur neck BS/BV, Tb.Th. and Tb.N. Female offspring exposed to adequate FA+ISO had higher (P=.005) BS/BV, lower (P= .003) Tb.Th. and higher (P=.012) Tb.N. compared to mice exposed to supplemental FA+ISO or adequate FA.
Early life exposure to adequate FA+ISO results in higher serum OPG and IGF-I in female mice at adulthood
Exposure to supplemental FA+ISO or supplemental FA alone did not result in altered serum biochemistry compared to adequate FA. Female offspring exposed to adequate FA+ISO had higher serum OPG (FA, P=.0075; ISO, P=.0173; FA × ISO, P=.0299) and IGF-I (Pb.05) concentrations than all other treatment groups (Fig. 3) . In addition, female offspring exposed to adequate FA+ISO had a two-fold higher (FA, P=.0067; ISO, P=.0061; FA × ISO, P=.05) ratio of OPG to RANKL compared to all other treatment groups (Fig. 3 ). There were no differences in serum RANKL, osteocalcin or ACTH concentrations among groups (Fig. 3) .
Early life exposure to adequate FA+ISO or supplemental FA without ISO suppresses DNA methyltransferase expression in long bones of adult female mice
Real-time RT-PCR analyses revealed that early life exposure to supplemental FA+ISO does not alter the expression of DNA methyltransferase (i.e. Dnmt1, Dnmt3a or Dnmt3b) in adult bone tissue. However, female offspring exposed to adequate FA+ISO or supplemental FA had significantly (Pb.05) lower Dnmt3a expression in bone than females exposed to adequate FA without ISO (Fig. 4) . ACTH -adrenocorticotropic hormone; CON -control; FA -folic acid; ISO -soy isoflavones; IGF -insulin growth factor; OPG -osteoprotegrin; RANKL -receptor activator of nuclear factor kappa-β ligand.
Microarray analyses of the femur
Since Dnmt3a plays a role in establishing DNA methylation patterns early in development and has the potential to modulate the expression of many genes, microarray analyses were performed to identify gene candidates. Out of 45281 genes represented on the Mouse WG-6v2r3 array, 30269 probes were analyzed. Out of these probes, 949 genes were identified to be statistically different among groups (Fig. 5A) . Out of these genes, 405, 118 and 113 genes were uniquely differentially expressed (Pb.05) by early life exposure to supplemental FA+ISO, adequate FA+ISO and supplemental FA, respectively (Fig. 5B) . From this cluster, 37 genes were differentially expressed by all three treatments (Fig. 5B) . Out of these 37 genes, one gene (Gdf10) was identified to be an important modulator in skeletal morphogenesis.
Gene ontology revealed that compared to adequate FA, exposure to supplemental FA+ISO or supplemental FA alone reduces the expression of genes involved in cell cycle regulation (Tables 2 and 3 ). In contrast, exposure to adequate FA+ISO up-regulates the expression of 8 genes in the 'isomerase activity' pathway (Table 2) . These genes are involved in protein folding, release of super-coiling and torsional tension of DNA, rearrangement of disulfide bonds and regulation of different receptors (Table 3) . Analysis of microarray data also demonstrated that the expression of mRNA encoding NPY was the second most highly altered gene with a 5.67-fold down-regulation in mice fed adequate FA+ISO (Table 3 ). This finding was confirmed by real-time PCR analysis which showed that female mice exposed to adequate FA+ISO or supplemental FA have significantly lower NPY mRNA expression at the femur than female mice exposed to adequate FA (Fig. 6 ).
Discussion
Contrary to our hypothesis, exposure to supplemental FA+ISO did not provide greater benefits to bone health than either treatment alone. Rather, female offspring whose mothers were fed an adequate FA diet, and were treated with ISO for the first 10-days of life had higher BMD, more bone volume (BV/TV) and greater trabecular connectivity (↑Tb.N. ↓Tb.Sp.) at the femur neck and lumbar spine than female offspring exposed to adequate FA alone. The higher mineral content and structural improvements resulted in stronger bones. In addition, these mice had higher levels of bone formation markers (i.e. OPG and IGF-I). Exposure to supplemental FA+ISO or supplemental FA alone provided some benefits to female bone but the effects were less pronounced than those induced by adequate FA+ISO. For example, female mice exposed to supplemental FA with or without ISO did not show any changes in bone formation markers or improvements in bone microarchitecture at the femur neck compared to females exposed to adequate FA alone.
Based on these observations we hypothesized that ISO and FA may be inducing their effects through the same mechanism, and that combining these two interventions may activate a negative feedback control system that attenuates or prevents the induction of biological effects. It is generally accepted that endocrine factors have continuous feedback systems that work together to signal the glands to regulate the amount of hormones present in circulation. While FA and ISO are not true endocrine factors, they can both modulate DNA methylation [32] and indirectly affect the expression of hormones, enzymes and transcription factors. Thus, it is possible that when given in combination during sensitive stages of development exposure to supplemental FA+ISO alters gene expression in such a way that prevents or attenuates the induction of biological effects induced by either treatment alone. To understand potential mechanisms by which adequate FA+ISO or supplemental FA alone result in stronger femurs and lumbar vertebra, we first measured the expression of DNA methyltransferases in long bones of adult female mice. Exposure to adequate FA+ISO or supplemental FA alone equally suppressed Dnmt3a expression in bone. Since Dnmt3a plays a role in setting up DNA methylation patterns during development and can alter the expression of many genes, we performed bone microarray analyses to compare the gene expression profiles among groups.
The finding that female mice exposed to supplemental FA+ISO, adequate FA+ISO or supplemental FA alone had 3% of their genes changed in bone at 6 weeks of age provided evidence that FA and ISO improve bone through an epigenetic mechanism. As expected, female mice exposed to supplemental FA+ISO had a higher number of differentially expressed genes (560 genes) than those exposed to adequate FA+ISO (260 genes) or supplemental FA (259 genes) (Fig. 5) . Importantly, the differentially expressed genes of female mice exposed to supplemental FA with or without ISO were involved in DNA synthesis, stability, integrity or repair -supporting the principle function of folate. However, based on the differences in bone outcome measures (i.e. BMD, bone structure, bone strength and serum markers of bone turnover) among groups, we knew that females exposed to adequate FA+ISO had some underlying change that was not present in mice exposed to adequate FA or supplemental FA+ISO. In examining microarray analyses we discovered that only females exposed to adequate FA+ISO had a 5.7-fold lower expression of neuropeptide Y (NPY) at the femur than females exposed to adequate FA alone. This finding was also confirmed using quantitative real-time PCR analyses and further showed that NPY is also down-regulated in femurs of females exposed to supplemental FA alone. The promoter of NPY spans over 246 base pairs and has 3 transcription factor binding sites (NGF-RE, AP-2 and NGFI-A) that contain CpG islands [33] , which indicates that imprinting of female bone may in part be mediated by NPY. Out of 949 genes that were identified to be differentially expressed in the mouse genome, NPY was the second most highly altered gene. The gene that was most profoundly altered in mRNA expression was A530055J02Rik, which is a non-coding RNA that was equally suppressed in all three treatment groups (supplemental FA+ISO, adequate FA+ISO, supplemental FA). Thus, NPY rather than A530055J02Rik is the more likely candidate responsible for bone improvement of female mice exposed to adequate FA+ISO or supplemental FA alone.
Widely expressed in the central and peripheral nervous system, NPY is an important regulator of many physiological processes, including bone and energy metabolism [34] . In bone, NPY inhibits osteoblast formation [35] , decreases osteoblast cell number [36] , reduces the expression of late stage genes that promote bone formation (i.e. osteoclacin and DMP-1) [37] and decreases mineral deposition [38] . Thus, the finding that female CD-1 mice exposed to adequate FA+ISO had undetectable levels of NPY mRNA expression in bone tissue at 6-weeks of age suggests that NPY may largely be responsible for the observed improvements in bone tissue (i.e. ↑ BMD, ↑ Tb.N, ↑ OPG/RANKL ratio, ↑ bone strength). Moreover, taking that genes are usually not expressed in isolation but rather in the context of other genes and their products, cells and tissues in a temporal and special dimension, the finding that NPY is down-regulated in bone tissue suggests that NPY gene expression may also be altered in other tissues. Until recently, scientists have viewed each tissue as an independent commodity, but emerging findings indicate that signaling pathways exist between tissues so studying whole-organism physiology is highly important. From published literature we know that there is a degree of connection between the NPY-mediated changes in bone and energy homeostasis [34] . However, the degree to which these processes are interrelated remains to be elucidated. In this study, we identified that females exposed to adequate FA+ISO during development have higher body weight from 4 through 16 weeks of age than those exposed to adequate FA alone. Although this finding has previously been shown [28] , this study is the first to demonstrate that ISO-induced effects on body weight depend on the level of FA exposure. Female CD-1 mice exposed to supplemental FA+ISO did not have significant changes in body weight compared to females exposed to supplemental FA. Therefore, it seems that both bone and adipose tissue respond most profoundly to adequate FA+ISO during development.
In summary, female mice exposed to adequate FA+ISO or supplemental FA alone had significant improvements in BMD, trabecular connectivity and resistance to fracture at the femur and lumbar spine when compared to females exposed to adequate FA alone, while improvements induced by supplemental FA+ISO were limited to higher BMD, trabecular connectivity and peak load at the lumbar spine. Based on the gene expression profiles we believe that these functional outcomes are in part a reflection of epigenetic or transcriptomic changes induced by suppression of Dnmt3a that include a significant down regulation in NPY. Fig. 6 . Expression of NPY, PTHr1 and Ctbb1 in bones of 4 month old female CD-1 mice whose mothers' were fed, adequate or supplemental FA during pregnancy and lactation, and who from PND 1-10 were treated with subcutaneous injections of corn oil or ISO. Total RNA isolated from bone and quantitative real-time PCR analyses confirmed that female mice exposed to adequate FA+ISO or supplemental FA have reduced NPY gene expression in comparison to mice exposed to adequate FA without ISO. PTHr1 and Ctnbb1 were not significantly different among groups. Values are expressed as mean±S.E.M., n=6/group. Bars without a common letter differ, Pb.05. Abbreviations: CON -control; FA -folic acid; ISO -soy isoflavones.
